分子病

fēn zǐ bìnɡ
  • molecular disease
分子病分子病
  1. Gregory教授,并且是哈佛大学公共健康学院分子遗传病流行学这个项目的主管,是这项研究的资深作者。

    Gregory Professor of Cancer Prevention and director of the Program in Molecular and Genetic Epidemiology at HSPH and senior author of the study .

  2. 中国部分地区传染性法氏囊病病毒分子流病学调查

    Investigation on Molecular Epidemiology of Infectious Bursal Disease in Parts of China

  3. 正分子精神病学会!

    AOP Academy of orthomolecular psychiatry thank you !

  4. 肺癌的发生、发展和演变与细胞原癌基因的激活和抑癌基因的失活有着密切的关系,并已证实肺癌是一种多基因分子异常病。

    Lung cancer , whose occurance , development and evolution are related to the activation of protooncogene and the inactivation of antioncogene , was proved to be a polygene molecular disorder disease .

  5. 共刺激分子在Graves病甲状腺组织中的表达

    Expression of Costimulatory Molecule in Thyroid Tissue of Graves ' Disease

  6. B7-1、CD40和CD54分子在Graves病患者甲状腺组织中的表达

    Expressions of B7-1 , CD40 and CD54 in thyroid tissue from patients with Graves ' disease

  7. 这种病原蛋白的本质是正常蛋白的异常折叠,因此又被称为蛋白分子的构象病。

    This pathogen is resulted from the toxic folding of normal protein .

  8. 利用分子标记对抗病基因进行分析;

    And the resistant genes contained in these cultivars were also identified with the use of molecular markers .

  9. 目的:通过对末端病大鼠跟腱末端组织中MMP-1、TIMP-1改变以及二者关系研究,从分子水平揭示末端病发病机制。

    Objective : Through the studies of expression of MMP-1 and TIMP-1 at the Enthesiopathy of Rat Achilles as well as the relations on molecular level , reveals its pathogenesis .

  10. 结论不同地区HbH患者的α珠蛋白基因的突变类型有明显的差异,该项研究为HbH病的分子遗传学和HbH病的基因诊断提供了依据。

    Conclusion The molecular abnormalities of α globin genes in HbH patients were significantly different in different regions . This study provides useful knowledge for the understanding the molecular genetics of HbH disease as well as for molecular diagnosis in the regions where the disease is prevalent .

  11. β2整合素及L-选择素粘附分子在恶性血液病表达特征的研究

    Expression of adhesion molecules β _2 integrins and selections in malignant hematopoietic diseases

  12. 我们采用一系列先进的分子生物学方法,来研究LDL-R和APOB这两个基因的点突变,从分子水平探讨血脂代谢异常的发病机理,进一步促进分子心血管病学的研究。

    To probe into the etiological mechanism of dyslipidemia at molecular level and enhance the development of molecular cardiovasology , we studied the point mutations of LDL-R and apo B using a series of advanced techniques of molecular biology .